ABN.AS: $40.75 ▲ 0.30 (0.74%)DSFIR.AS: $99.66 ▼ -0.99 (-0.98%)GMAB.CO: $2,487.00 ▲ 42.00 (1.72%)REP.MC: $29.21 ▼ -0.31 (-1.05%)SOON.SW: $267.80 ▲ 3.20 (1.21%)CRWD: $263.11 ▼ -11.94 (-4.34%)HPE: $70.01 ▼ -3.45 (-4.70%)AMD: $590.56 ▼ -17.54 (-2.88%)DELL: $571.03 ▼ -15.03 (-2.56%)PANW: $399.00 ▼ -19.78 (-4.72%)MRNA: $211.72 ▼ -13.28 (-5.90%)AAPL: $340.13 ▲ 3.49 (1.04%)AMZN: $259.64 ▼ -2.79 (-1.06%)MSFT: $540.11 ▲ 5.04 (0.94%)NVDA: $226.49 ▼ -2.79 (-1.22%)CIEN: $400.41 ▼ -49.36 (-10.97%)DDOG: $287.65 ▼ -5.62 (-1.91%)SNPS: $501.64 ▼ -8.35 (-1.64%)CAP.PA: $115.35 ▲ 0.30 (0.26%)TSCO.L: $511.00 ▲ 7.20 (1.43%)WKL.AS: $77.16 ▲ 2.16 (2.88%)

Company Details

Janus Henderson Global Life Sciences Fund Class C

JFNCX - NASDAQ

Identifiants & Marche

Ticker JFNCX
ISIN US4710234737
CIK 0000277751
Bourse NASDAQ
Devise USD

Classification

Entreprise

Pays US
Siege N/A
Fondee N/A
Site Web N/A

Description

The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.